Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.
about
Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEuropPotential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malariaIntermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trialPyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement.Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the GambiaIndependent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia.Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.Malaria chemoprophylaxis: when should we use it and what are the options?CYP2C8 and antimalaria drug efficacy.Chloroquine resistance before and after its withdrawal in Kenya.Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets.Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.
P2860
Q24807035-04177E97-2A47-4D0A-A7B7-53FE966AD251Q28468762-0A8870FC-E8C4-46EE-9649-A54B0DD6DD11Q28473566-1CCCC4BD-66FB-41D8-940D-4E21BDCE08C4Q34191903-8048E89C-DE4A-43D2-B536-7D7A88619AB2Q34743292-F014104F-C412-4C13-A4F1-25EE4856C9D0Q34894294-87A00C55-B8AA-4962-9781-1CB3885F6680Q35031434-9E0B875B-7AC2-438D-B385-ED18CAEAE0C9Q35647764-AA388417-741B-41CD-9271-FDF48E153634Q35827434-7A2D57E3-71D4-4846-82DF-780E232627B0Q35838600-501ACD16-0907-4A13-85ED-BE58E8FED2FCQ35917341-68E0F408-4960-43F0-ACD8-6E8F150D4BFAQ36730638-0F567C87-FA8B-4503-87AE-25C24EE93492Q37223629-BC2A6DD5-48D2-4A54-B359-B59CA09014FFQ39557015-25C316B8-2522-45B1-BA64-E4D570A2C551Q43066760-89F3755C-DA45-43D1-B133-ED0BA286C542Q43796087-8109D1B0-139C-46DE-A8E6-8F2DA89D0489
P2860
Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Chlorproguanil/dapsone for unc ...... inetics and therapeutic range.
@en
Chlorproguanil/dapsone for unc ...... inetics and therapeutic range.
@nl
type
label
Chlorproguanil/dapsone for unc ...... inetics and therapeutic range.
@en
Chlorproguanil/dapsone for unc ...... inetics and therapeutic range.
@nl
prefLabel
Chlorproguanil/dapsone for unc ...... inetics and therapeutic range.
@en
Chlorproguanil/dapsone for unc ...... inetics and therapeutic range.
@nl
P2093
P1476
Chlorproguanil/dapsone for unc ...... inetics and therapeutic range.
@en
P2093
P304
P356
10.1016/S0035-9203(97)90093-6
P50
P577
1997-05-01T00:00:00Z